Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases

Surgical Oncology

Volumn 17, Issue 3, 2008, Pages 237-245

  Delpech, Yann ^a   Coutant, Charles ^a   Darai, Emile ^a   Barranger, Emmanuel ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Endometrial cancer; Histopathological detection; Micrometastasis; Prognosis; Sentinel lymph node

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; DECISION MAKING; DISSECTION; ENDOMETRIUM CANCER; FALSE NEGATIVE RESULT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 50049095020     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.04.001     Document Type: Review

References (66)

1. Hacker N. Uterine cancer. In: Berek J., and Hacker N. (Eds). Practical gynecologic oncology (2005), Lipincott Williams & Wilkins, Philadelphia 397-442
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 2007 57 (2007) 43-66
3. Lurain J.R., Rice B.L., Rademaker A.W., Poggensee L.E., Schink J.C., and Miller D.S. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78 (1991) 63-69
4. Mariani A., Webb M.J., Keeney G.L., Aletti G., and Podratz K.C. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84 (2002) 437-442
5. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 (1987) 2035-2041
6. Lyman G.H., Giuliano A.E., Somerfield M.R., Benson III A.B., Bodurka D.C., Burstein H.J., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
7. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Elashoff R., Essner R., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
8. Veronesi U., Galimberti V., Mariani L., Gatti G., Paganelli G., Viale G., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
9. Delpech Y., Cortez A., Coutant C., Callard P., Uzan S., Darai E., et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol 18 (2007) 1799-1803
10. Altgassen C., Pagenstecher J., Hornung D., Diedrich K., and Hornemann A. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 105 (2007) 457-461
11. Barranger E., Cortez A., Grahek D., Callard P., Uzan S., and Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol 11 (2004) 344-349
12. Bats A.S., Clement D., Larousserie F., Le Frere-Belda M.A., Pierquet-Ghazzar N., Hignette C., et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol 97 (2008) 141-145
13. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., and Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62 (1996) 169-173
14. Delaloye J.F., Pampallona S., Chardonnens E., Fiche M., Lehr H.A., De Grandi P., et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol 106 (2007) 89-93
15. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., and Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 92 (1999) 204-208
16. Fersis N., Gruber I., Relakis K., Friedrich M., Becker S., Wallwiener D., et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 25 (2004) 339-342
17. Frumovitz M., Bodurka D.C., Broaddus R.R., Coleman R.L., Sood A.K., Gershenson D.M., et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104 (2007) 100-103
18. Gargiulo T., Giusti M., Bottero A., Leo L., Brokaj L., Armellino F., et al. Sentinel lymph node (SLN) laparoscopic assessment early stage in endometrial cancer. Minerva Ginecol 55 (2003) 259-262
19. Gien L.T., Kwon J.S., and Carey M.S. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Can 27 (2005) 1107-1112
20. Holub Z., Jabor A., and Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol 23 (2002) 53-57
21. Holub Z., Jabor A., Lukac J., and Kliment L. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit 10 (2004) CR587-CR591
22. Li B., Li X.G., Wu L.Y., Zhang W.H., Li S.M., Min C., et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bull Cancer 94 (2007) E1-E4
23. Lopes L.A., Nicolau S.M., Baracat F.F., Baracat E.C., Goncalves W.J., Santos H.V., et al. Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer 17 (2007) 1113-1117
24. Maccauro M., Lucignani G., Aliberti G., Villano C., Castellani M.R., Solima E., et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 32 (2005) 569-574
25. Niikura H., Okamoto S., Yoshinaga K., Nagase S., Takano T., Ito K., et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol 105 (2007) 683-686
26. Niikura H., Okamura C., Utsunomiya H., Yoshinaga K., Akahira J., Ito K., et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92 (2004) 669-674
27. Pelosi E., Arena V., Baudino B., Bello M., Gargiulo T., Giusti M., et al. Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 88 (2002) S9-S10
28. Pelosi E., Arena V., Baudino B., Bello M., Giusti M., Gargiulo T., et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 24 (2003) 971-975
29. Raspagliesi F., Ditto A., Kusamura S., Fontanelli R., Vecchione F., Maccauro M., et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol 191 (2004) 435-439
30. Van Dam P., Sonnemans H., Van Dam P.J., Smet D., Verkinderen L., and Dirix L.Y. Sentinel node detection in a patient with recurrent endometrial cancer initially treated by hysterectomy and radiotherapy. Int J Gynecol Cancer 14 (2004) 673-676
31. Holub Z., Kliment L., Lukac J., and Voracek J. Laparoscopically-assisted intraoperative lymphatic mapping in endometrial cancer: preliminary results. Eur J Gynaecol Oncol 22 (2001) 118-121
32. Singletary S.E., Allred C., Ashley P., Bassett L.W., Berry D., Bland K.I., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
33. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet 335 (1990) 1565-1568
34. Mariani A., Webb M.J., Keeney G.L., and Podratz K.C. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81 (2001) 100-104
35. Malur S., Krause N., Kohler C., and Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 80 (2001) 254-257
36. Plante M., Renaud M.C., Tetu B., Harel F., and Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 91 (2003) 494-503
37. Yokoyama Y., Maruyama H., Sato S., and Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 64 (1997) 411-417
38. Henriksen E. The lymphatic dissemination in endometrial carcinoma. A study of 188 necropsies. Am J Obstet Gynecol 123 (1975) 570-576
39. Matsumoto K., Yoshikawa H., Yasugi T., Onda T., Nakagawa S., Yamada M., et al. Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Lett 180 (2002) 83-89
40. Bradley W.H., Boente M.P., Brooker D., Argenta P.A., Downs L.S., Judson P.L., et al. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol 104 (2004) 1030-1033
41. Obermair A., Geramou M., Gucer F., Denison U., Graf A.H., Kapshammer E., et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C. Cancer 88 (2000) 139-143
42. Takac I., and Zegura B. Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer. Gynecol Oncol 107 (2007) 94-98
43. Hirahatake K., Hareyama H., Sakuragi N., Nishiya M., Makinoda S., and Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65 (1997) 82-87
44. Lewandowski G., Torrisi J., Potkul R.K., Holloway R.W., Popescu G., Whitfield G., et al. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates. Gynecol Oncol 36 (1990) 401-404
45. Hauspy J., Beiner M., Harley I., Ehrlich L., Rasty G., and Covens A. Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 105 (2007) 285-290
46. Schwartz G.F., Giuliano A.E., and Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia. Pennsylvania. Hum Pathol 33 (2002) 579-589
47. Lawrence W.D. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch 439 (2001) 601-603
48. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione-Gertsch M., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900
49. Reich O., Winter R., Pickel H., Tamussino K., Hass J., and Petru E. Does the size of pelvic lymph nodes predict metastatic involvement in patient with endometrial cancer?. Int J Gynecol Cancer 6 (1996) 445-447
50. Gonzalez Bosquet J., Keeney G.L., Mariani A., Webb M.J., and Cliby W.A. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol 91 (2003) 518-525
51. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 80 (2001) 139-144
52. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
53. Listrom M.B., and Dalton L.W. Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2. Am J Clin Pathol 88 (1987) 297-301
54. Woodcock-Mitchell J., Eichner R., Nelson W.G., and Sun T.T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95 (1982) 580-588
55. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G., and Podratz K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 182 (2000) 1506-1519
56. Fishman A., Klein A., Zemer R., Zimlichman S., Bernheim J., Cohen I., et al. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gynecol Oncol 77 (2000) 399-404
57. Rampaul R.S., Miremadi A., Pinder S.E., Lee A., and Ellis I.O. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 3 (2001) 113-116
58. de Mascarel I., Bonichon F., Coindre J.M., and Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66 (1992) 523-527
59. McGuckin M.A., Cummings M.C., Walsh M.D., Hohn B.G., Bennett I.C., and Wright R.G. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73 (1996) 88-95
60. Greenson J.K., Isenhart C.E., Rice R., Mojzisik C., Houchens D., and Martin Jr. E.W. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73 (1994) 563-569
61. Liefers G.J., Cleton-Jansen A.M., van de Velde C.J., Hermans J., van Krieken J.H., Cornelisse C.J., et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339 (1998) 223-228
62. Maehara Y., Oshiro T., Endo K., Baba H., Oda S., Ichiyoshi Y., et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 119 (1996) 397-402
63. Izbicki J.R., Hosch S.B., Pichlmeier U., Rehders A., Busch C., Niendorf A., et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337 (1997) 1188-1194
64. Edelstein R.A., Zietman A.L., de las Morenas A., Krane R.J., Babayan R.K., Dallow K.C., et al. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology 47 (1996) 370-375
65. Mariani A., Webb M.J., Galli L., and Podratz K.C. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76 (2000) 348-356
66. Onda T., Yoshikawa H., Mizutani K., Mishima M., Yokota H., Nagano H., et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 75 (1997) 1836-1841